Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Камнерастворяющая терапия коралловидных конкрементов
________________________________________________
Bazhenov I.V., Zyryanov A.V., Danilov V.O. et al. Stone-dissolving therapy of coral calculus. Consilium Medicum. 2019; 21 (7): 64–68. DOI: 10.26442/20751753.2019.7.190468
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: коралловидный нефролитиаз, литолитическая терапия.
________________________________________________
Key words: staghorn nephrolithiasis, litholytic therapy.
2. Gutman AB, Yue TF. Urinary ammonium excretion in primary gout. J Clin Invest 1965; 44: 1474–81.
3. Maalouf NM. Metabolic syndrome and the genesis of uric acid stones. J Ren Nutr 2011; 21: 128–31.
4. Maalouf NM, Cameron MA, Moe OW, Sakhaee K. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 2004; 13: 181–9.
5. Cho ST, Jung SI, Myung SC, Kim TH. Correlation of metabolic syndrome with urinary stone composition. Int J Urol 2013; 20: 208–13.
6. Rodman JS et al. Dissolution of uric acid calculi. J Urol 1984; 131: 1039.
7. Becker G. Uric acid stones. Nephrology 2007; 12: S21.
8. Spettel S, Shah P, Sekhar K et al. Using Hounsfield unit measurement and urine parameters to predict uric acid stones. Urology 2013; 82: 22–6.
9. Reichard C, Gill BC, Sarkissian C et al. 100% uric acid stone formers: what makes them different? Urology 2015; 85: 296–8.
10. Trinchieri A, Esposito N, Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate. Arch Ital Urol Androl 2009; 81: 188–91.
11. Sinha M, Prabhu K, Venkatesh P, Krishnamoorthy V. Results of urinary dissolution therapy for radiolucent calculi. Int Braz J Urol 2013; 39: 103–7.
12. Barbera M, Tsirgiotis A, Barbera M, Paola Q. The importance of potassium citrate and potassium bicarbonate in the treatment of uric acid renal stones. Arch Ital Urol Androl 2016; 88 (4): 341–2. DOI: 10.4081/aiua.2016.4.341
________________________________________________
1. Sakhaee K. Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol 2014; 27: 241–5.
2. Gutman AB, Yue TF. Urinary ammonium excretion in primary gout. J Clin Invest 1965; 44: 1474–81.
3. Maalouf NM. Metabolic syndrome and the genesis of uric acid stones. J Ren Nutr 2011; 21: 128–31.
4. Maalouf NM, Cameron MA, Moe OW, Sakhaee K. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 2004; 13: 181–9.
5. Cho ST, Jung SI, Myung SC, Kim TH. Correlation of metabolic syndrome with urinary stone composition. Int J Urol 2013; 20: 208–13.
6. Rodman JS et al. Dissolution of uric acid calculi. J Urol 1984; 131: 1039.
7. Becker G. Uric acid stones. Nephrology 2007; 12: S21.
8. Spettel S, Shah P, Sekhar K et al. Using Hounsfield unit measurement and urine parameters to predict uric acid stones. Urology 2013; 82: 22–6.
9. Reichard C, Gill BC, Sarkissian C et al. 100% uric acid stone formers: what makes them different? Urology 2015; 85: 296–8.
10. Trinchieri A, Esposito N, Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate. Arch Ital Urol Androl 2009; 81: 188–91.
11. Sinha M, Prabhu K, Venkatesh P, Krishnamoorthy V. Results of urinary dissolution therapy for radiolucent calculi. Int Braz J Urol 2013; 39: 103–7.
12. Barbera M, Tsirgiotis A, Barbera M, Paola Q. The importance of potassium citrate and potassium bicarbonate in the treatment of uric acid renal stones. Arch Ital Urol Androl 2016; 88 (4): 341–2. DOI: 10.4081/aiua.2016.4.341
1 ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России, Екатеринбург, Россия;
2 ГБУЗ СО «Свердловская областная клиническая больница №1», Екатеринбург, Россия
*filippova.cat@yandex.ru
________________________________________________
Igor V. Bazhenov1,2, Alexander V. Zyryanov1, Viktor O. Danilov2, Еkaterina S. Philippova*1,2, Albert A. Makaryan1, Pavel D. Bessonov2, Sergey A. Burcev2
1 Ural State Medical University, Ekaterinburg, Russia;
2 Sverdlovsk Regional Clinical Hospital №1, Ekaterinburg, Russia
*filippova.cat@yandex.ru